Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

InduPro raises $77M, begins first human trial of cancer drug

Дата публикации: 14-08-2026 13:33:34


Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, as the company advances its novel approach to targeting tumor cells. Read More

Основное содержимое страницы с новостью.

Please enable cookies.

Sorry, you have been blocked You are unable to access geekwire.com
Why have I been blocked?

This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.

What can I do to resolve this?

You can email the site owner to let them know you were blocked. Please include what you were doing when this page came up and the Cloudflare Ray ID found at the bottom of this page.

Cloudflare Ray ID: a2e167b00e69c8bd Your IP: 45.147.101.248 Performance & security by Cloudflare

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Prof. Peter Littrup | The Future of Cancer Care May Already Be Here, and May Hold Faster Promise for Neurologic Diseases06.1111-08-2026
2Startup Spotlight: ScopeSys gives drugmakers a closer look inside genomic medicines021.8513-08-2026
3В Индии разработали таблетку от рака, призванную заменить химиотерапию06.419-08-2026
4 Altum Sequencing prepara la expansión de su ‘radar’ contra el cáncer 010.4220-08-2026
5Closed Pfizer biopharma facility in Everett gets a new owner and a mystery tenant015.0214-08-2026
6Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science025.118-08-2026
7Российские ученые создали новый способ доставки лекарства к опухоли010.330-07-2026
8Фармасинтез зарегистрировал первый российский оригинальный препарат для лечения хронического миелоидного лейкоза07.0322-07-2026
9Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed By Utebzi Milestones And Royalties0714-07-2026
10UW researchers simplify production of promising targeted cancer therapies012.7412-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 18.71. Источник: www.geekwire.com.